The FDA is aware that Intuitive Surgical (ISRG) has issued a letter to affected customers recommending all 8mm SureForm 30 gray reloads for curved-tip staplers be removed from where they are used or sold. On March 11, 2026, Intuitive Surgical sent all affected customers a letter, the FDA said, noting that the agency “has identified this recall as the most serious type.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical Expands Equity Plan and Buyback Authorization
- Private Markets: True Anomaly lands $650M, Polymarket pushes for U.S. return
- Intuitive Surgical (ISRG) Beats Q1 Expectations. The Bull Case Builds
- Intuitive Surgical price target lowered to $651 from $712 at Barclays
- Intuitive Surgical Earnings Call Signals Robust Growth